We partner with experienced entrepreneurs and scientists to build companies around innovative science. Our network of current and former entrepreneurs in residence complement and enhance our partnerships with scientific founders.
Mediar Therapeutics, Board of Directors
Tilos Therapeutics, Founding CEO
(Acquired by Merck)
Ncontrol Therapeutics, Founding CEO
CoStim, Co-Founder, President
(Acquired by Novartis)
Brave Bio, Board of Directors
SeQure DX, Founding CEO
FireCyte Therapeutics, Founding CEO
At Mass General Brigham Ventures, diversity, equity and inclusion are central to every aspect of our organization. When our workforce is more equitable and inclusive, we can be more innovative, creative, and on the cutting edge of advancement. Leveraging diverse perspectives allows us to develop better overall solutions to the problems we face.